Physician profile
Heather E Brooks
NPI 1184637456
$257.27
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $62.33 · 2020: $37.72 · 2021: $70.95 · 2022: $86.27.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Minimed, INC. | $52.08 | 2019-2020 | |
| Glaxosmithkline, LLC. | $39.30 | 2021-2022 | |
| Medtronic, INC. | $35.92 | 2022 | |
| Lilly USA, LLC | $25.44 | 2021-2022 | |
| Dexcom, INC. | $22.22 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.14 | 2021 | |
| Tandem Diabetes Care, INC. | $15.20 | 2022 | |
| Amarin Pharma, INC. | $13.04 | 2020 | |
| Novo Nordisk INC | $12.49 | 2019 | |
| Insulet Corporation | $11.25 | 2019 | |
| Abbvie INC. | $11.19 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Brooks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.